All lobbying filings

THE CONSILIO GROUP

Lobbying for N BRERETON MEDICAL TECHNOLOGIES · Opiod prevention through a titration-based methodology.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 23, 2025

Income

$15,000.00

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Lobbyists on this filing 2

OLIVER MEISSNER

Previously held: CEO
BRANDON KIRBY

Previously held: Director of Government Relations

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Natl Institutes of Health (NIH)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Alcohol and Drug Abuse

FenBlock is a patented, non-invasive medical device designed to help patients safely taper off prescribed fentanyl patches by gradually reducing the amount of medication absorbed through the skin.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.